Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAH-box helicase 40 pseudogene 1 (DHX40P1) is an *unprocessed pseudogene* related to the DEAH-box helicase 40 gene (DHX40)[2][4][6]. As a pseudogene, DHX40P1 is not believed to encode a functional protein and lacks evidence for a biological role or pathogenic involvement. It is distinct from the protein-coding DHX40 gene, which is an RNA helicase involved in RNA metabolism and cancer predisposition[2][4][6]. Pseudogenes such as DHX40P1 do not encode functional protein products and are not considered molecular targets for drugs, diagnostic biomarkers, or mechanistic studies. Therefore, DHX40P1 is not a therapeutic target, and there is no evidence for biological functions or disease association[2][4][6]. Only the protein-coding parent gene, *DHX40*, is being studied for biological or pathological roles (e.g., in cancer); all attributes related to mechanism, expression, functions, and disease derive from *DHX40*, not DHX40P1[1][4][6]. If you are looking for a druggable target, the correct entity would be the protein-coding "DEAH-box helicase 40" (DHX40), not the pseudogene DHX40P1[1][2][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAH-box helicase 40 pseudogene 1 (DHX40P1).